Alonso-Navarro, Hortensia <br/><br/>
[The role of CYP2C19 polymorphism in the development of adverse effects to drugs and the risk for diseases].  [electronic resource] 

 -  Medicina clinica  May 2006 
 - 697-706 p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>0025-7753 
<br/><br/><label>Standard No.: </label>10.1157/13088772  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aryl Hydrocarbon Hydroxylases--genetics<br/>Cytochrome P-450 CYP2C19<br/>Drug-Related Side Effects and Adverse Reactions<br/>Genetic Predisposition to Disease<br/>Humans<br/>Mixed Function Oxygenases--genetics<br/>Pharmacogenetics<br/>Polymorphism, Genetic